Cost-Effectiveness of HIV Treatment in Resource-Poor Settings — The Case of Côte d'Ivoire
Top Cited Papers
- 14 September 2006
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 355 (11) , 1141-1153
- https://doi.org/10.1056/nejmsa060247
Abstract
As antiretroviral therapy is increasingly used in settings with limited resources, key questions about the timing of treatment and use of diagnostic tests to guide clinical decisions must be addressed.Keywords
This publication has 40 references indexed in Scilit:
- Scaling Up AIDS Treatment: What Is the Potential Impact and What Are the Risks?PLoS Medicine, 2005
- Integrating HIV Prevention and Treatment: From Slogans to ImpactPLoS Medicine, 2005
- Costs of scaling up health interventions: a systematic reviewHealth Policy and Planning, 2005
- Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in SenegalAIDS, 2003
- Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease riskThe Lancet, 2003
- Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Côte d'IvoireAIDS, 2003
- HIV prevention before HAART in sub-Saharan AfricaThe Lancet, 2002
- Resource Needs for HIV/AIDSScience, 2001
- The Cost Effectiveness of Combination Antiretroviral Therapy for HIV DiseaseNew England Journal of Medicine, 2001
- Sustained CD4+T Cell Response after Virologic Failure of Protease Inhibitor–Based Regimens in Patients with Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 2000